Targeted therapy for cancer of the uterus
Targeted therapy is a new kind of drug treatment that attacks specific features of cancer cells to stop the cancer growing and spreading. Your oncologist may discuss additional testing of the tumour to see whether any of these drugs might be an option, particularly for cancer that has returned.
Targeted therapy drugs are not yet standard treatment for cancer of the uterus, but you can ask your oncologist whether you may be able to access them through a clinical trial.
For more on this, see Targeted therapy.
Listen to our podcast on New Treatments – Immunotherapy and Targeted Therapy
Video: What is targeted therapy?
A/Prof Alison Brand, Director, Gynaecological Oncology, Westmead Hospital, NSW; Kate Barber, 13 11 20 Consultant, Cancer Council Victoria; Prof Jonathan Carter, Director, Gynaecological Oncology, Chris O’Brien Lifehouse, NSW; Dr Robyn Cheuk, Senior Radiation Oncologist, Royal Brisbane and Women’s Hospital, QLD; Dr Alison Davis, Medical Oncologist, Canberra Region Cancer Centre, The Canberra Hospital, ACT; Kim Hobbs, Clinical Specialist Social Worker, Westmead Hospital, NSW; Nicole Kinnane, Nurse Coordinator, Gynaecology Oncology, Peter MacCallum Cancer Centre, VIC; Jennifer Loveridge, Consumer; Pauline Tanner, Gynaecology Cancer Nurse Coordinator, WA Cancer & Palliative Care Network, North Metropolitan Health Service, WA. We also thank the health professionals, consumers and editorial teams who have worked on previous editions of this title.
View the Cancer Council NSW editorial policy.
Click below to download a PDF booklet on this topic.
Targeted therapy is a type of drug treatment that attacks specific features of cancer cells, known as molecular targets, to stop the cancer growing and spreading. Other names for targeted therapy include biological therapies and molecular targeted therapy.